| scholarly article | Q13442814 |
| P50 | author | Ann M Leen | Q98164176 |
| P2093 | author name string | A B Rickinson | |
| J Brooks | |||
| S P Lee | |||
| E Landais | |||
| G S Taylor | |||
| E Houssaint | |||
| C-W Tsang | |||
| N H Gudgeon | |||
| T A Haigh | |||
| H M Long | |||
| P2860 | cites work | Efficient class II major histocompatibility complex presentation of endogenously synthesized hepatitis C virus core protein by Epstein-Barr virus-transformed B-lymphoblastoid cell lines to CD4(+) T cells | Q27469572 |
| Natural variants of the immunodominant HLA A11-restricted CTL epitope of the EBV nuclear antigen-4 are nonimmunogenic due to intracellular dissociation from MHC class I:peptide complexes | Q28268018 | ||
| Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines | Q30305718 | ||
| Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1. | Q30305830 | ||
| Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1. | Q30442797 | ||
| Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response | Q30442835 | ||
| Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting | Q33789613 | ||
| Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases | Q34052687 | ||
| Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory | Q34190038 | ||
| Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development | Q36231451 | ||
| Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies | Q36231550 | ||
| Anchor sequence-dependent endogenous processing of human immunodeficiency virus 1 envelope glycoprotein gp160 for CD4+ T cell recognition | Q36350632 | ||
| Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory | Q36367550 | ||
| Cytolytic CD4+-T-Cell Clones Reactive to EBNA1 Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation | Q36890569 | ||
| Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses | Q39607047 | ||
| Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy | Q40649977 | ||
| CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes | Q40669542 | ||
| Inhibition of EBV-induced lymphoproliferation by CD4(+) T cells specific for an MHC class II promiscuous epitope | Q40712449 | ||
| The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4 | Q41223097 | ||
| Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance | Q41258361 | ||
| Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection | Q41464315 | ||
| Capture and processing of exogenous antigens for presentation on MHC molecules. | Q41464375 | ||
| MHC class II-restricted presentation of intracellular antigen | Q41694984 | ||
| Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help | Q42642562 | ||
| Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity | Q42723067 | ||
| Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation | Q44618759 | ||
| Expression of Epstein-Barr virus nuclear antigen 1,2A and 2B in the baculovirus expression system: serological evaluation of human antibodies to these proteins | Q44912422 | ||
| A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. | Q44952697 | ||
| Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion | Q45837679 | ||
| Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4(+) T cells. | Q45857428 | ||
| EBV persistence in memory B cells in vivo. | Q52037383 | ||
| Class I processing-defective Burkitt's lymphoma cells are recognized efficiently by CD4+ EBV-specific CTLs | Q73224609 | ||
| Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy | Q73271294 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 4896-4907 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines | |
| P478 | volume | 79 |
| Q37713951 | Adenovirus-based vaccines against rhesus lymphocryptovirus EBNA-1 induce expansion of specific CD8+ and CD4+ T cells in persistently infected rhesus macaques. |
| Q42229225 | Age-associated Epstein-Barr virus-specific T cell responses in seropositive healthy adults. |
| Q21131584 | An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link |
| Q59358390 | Antibodies conjugated with viral antigens elicit a cytotoxic T cell response against primary CLL ex vivo |
| Q28554487 | Azidothymidine Sensitizes Primary Effusion Lymphoma Cells to Kaposi Sarcoma-Associated Herpesvirus-Specific CD4+ T Cell Control and Inhibits vIRF3 Function |
| Q34189497 | Burkitt Lymphoma: Pathogenesis and Immune Evasion |
| Q41788823 | CD4 T cells mediate killing during persistent gammaherpesvirus 68 infection |
| Q42170835 | CD4+ T-cell responses to Epstein-Barr virus nuclear antigen EBNA1 in Chinese populations are highly focused on novel C-terminal domain-derived epitopes. |
| Q41807836 | Cooperation between Epstein-Barr virus immune evasion proteins spreads protection from CD8+ T cell recognition across all three phases of the lytic cycle |
| Q39825102 | Cytolytic mechanisms and T-cell receptor Vbeta usage by ex vivo generated Epstein-Barr virus-specific cytotoxic T lymphocytes |
| Q37597931 | Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection? |
| Q21296742 | Cytotoxic CD4 T cells in antiviral immunity |
| Q42066029 | Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition |
| Q35616090 | Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers |
| Q38949843 | Down-regulation of LPA receptor 5 contributes to aberrant LPA signalling in EBV-associated nasopharyngeal carcinoma |
| Q41012612 | EBV-Associated Cancer and Autoimmunity: Searching for Therapies. |
| Q35994831 | Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination |
| Q38597250 | Epstein-Barr Virus-Specific Humoral Immune Responses in Health and Disease |
| Q34116845 | Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2. |
| Q37369220 | Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells. |
| Q35914342 | Epstein-barr virus: environmental trigger of multiple sclerosis? |
| Q64072993 | Extensive epigenetic and transcriptomic variability between genetically identical human B-lymphoblastoid cells with implications in pharmacogenomics research |
| Q37667998 | Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells |
| Q36641746 | Herpesvirus interference with major histocompatibility complex class II-restricted T-cell activation |
| Q38046606 | Herpesviruses placating the unwilling host: manipulation of the MHC class II antigen presentation pathway |
| Q64374688 | Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas |
| Q64374866 | Heterologous prime-boost vaccination protects from EBV antigen expressing lymphomas |
| Q37512260 | How human tumor viruses make use of autophagy |
| Q39097082 | Human immunity against EBV-lessons from the clinic. |
| Q35034278 | IRF-4-mediated CIITA transcription is blocked by KSHV encoded LANA to inhibit MHC II presentation |
| Q37041507 | Immune escape by Epstein-Barr virus associated malignancies |
| Q60306812 | Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in mice |
| Q41148685 | Impact of γ-chain cytokines on EBV-specific T cell cultures. |
| Q55265317 | Impaired Control of Epstein-Barr Virus Infection in B-Cell Expansion with NF-κB and T-Cell Anergy Disease. |
| Q36155542 | Kaposi's sarcoma-associated herpesvirus inhibits expression and function of endothelial cell major histocompatibility complex class II via suppressor of cytokine signaling 3 |
| Q45363582 | Long-term carriers generate Epstein-Barr virus (EBV)-specific CD4(+) and CD8(+) polyfunctional T-cell responses which show immunodominance hierarchies of EBV proteins. |
| Q40471906 | MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response. |
| Q35688231 | Macroautophagy Proteins Assist Epstein Barr Virus Production and Get Incorporated Into the Virus Particles. |
| Q47191093 | Membranal and blood-soluble HLA class II peptidome analyses using data-dependent and independent acquisition |
| Q33719767 | Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display. |
| Q37019458 | Patients with Epstein Barr virus-positive lymphomas have decreased CD4(+) T-cell responses to the viral nuclear antigen 1. |
| Q42282416 | Peptide matching between Epstein-Barr virus and human proteins |
| Q26852071 | Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus |
| Q36736361 | Primary B Lymphocytes Infected with Kaposi's Sarcoma-Associated Herpesvirus Can Be Expanded In Vitro and Are Recognized by LANA-Specific CD4+ T Cells |
| Q91900147 | Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells |
| Q64104879 | Progress in EBV Vaccines |
| Q37780705 | Prospects of a novel vaccination strategy for human gamma-herpesviruses |
| Q44968633 | Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD. |
| Q42723067 | Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity |
| Q36407109 | Repertoire and frequency of immune cells reactive to Epstein-Barr virus-derived autologous lymphoblastoid cell lines |
| Q37773234 | Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer |
| Q33519520 | T cell detection of a B-cell tropic virus infection: newly-synthesised versus mature viral proteins as antigen sources for CD4 and CD8 epitope display |
| Q38597252 | T-Cell Responses to EBV. |
| Q36116754 | The Cellular Localization of Human Cytomegalovirus Glycoprotein Expression Greatly Influences the Frequency and Functional Phenotype of Specific CD4+ T Cell Responses |
| Q40033016 | The DNase of gammaherpesviruses impairs recognition by virus-specific CD8+ T cells through an additional host shutoff function |
| Q33396983 | The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation |
| Q39625133 | The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathways |
| Q39527101 | The role of tetraspanin CD63 in antigen presentation via MHC class II. |
| Q33650689 | Virus and autoantigen-specific CD4+ T cells are key effectors in a SCID mouse model of EBV-associated post-transplant lymphoproliferative disorders |
| Q34434702 | Virus and cell RNAs expressed during Epstein-Barr virus replication |
| Q36228485 | Virus-specific CD4+ T cells: ready for direct attack |
Search more.